Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis

Translational Oncogenomics

Volumn 2008, Issue 3, 2008, Pages 81-98

  Gangoiti, Patricia ^a   Granado, Maria H ^a   Alonso, Alicia ^a,b   Goñi, Félix M ^a,b   Gómez Muñoz, Antonio ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CSIC UPV Unidad de Biofisica UBF   (Spain)

Author keywords

Apoptosis; Cell growth; Ceramide; Ceramide 1 phosphate; Sphingolipids; Sphingosine 1 phosphate

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CERAMIDE; CERAMIDE 1 PHOSPHATE; DOXORUBICIN; ETOPOSIDE; F 1209A; FENRETINIDE; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PHOSPHOTRANSFERASE INHIBITOR; SAFINGOL; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; SPHINGOSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CELL TYPE; DRUG MECHANISM; HUMAN; METASTASIS; MITOGENICITY; MOLECULAR DYNAMICS; NONHUMAN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

EID: 77953405065     PISSN: None     EISSN: 11772727     Source Type: Journal    
DOI: None     Document Type: Review

References (232)

1. Abe, A., Inokuchi, J., Jimbo, M. et al. 1992. Improved inhibitors of glucosylceramide synthase. J. Biochem., 111: 191-6.
2. Ancellin, N. and Hla, T. 1999. Differential pharmacological properties and signal transduction ofthe spbingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J. Biol. Chem., 274(27):18997-19002.
3. Ancellin, N., Colmont, C., Su, J. et al. 2002. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem., 277(8):6667-75.
4. Bajalieh, S.M., Martin, T.F. and Floor, E. 1989. Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. J. Biol. Chem., 264(24):14354-60.
5. Banno, Y., Takuwa, Y., Akao, Y. et al. 2001. Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of phosphatidylinositol 3-kinase and Akt in Chinese hamster ovary cells overexpressing EDG3. J. Biol. Chem., 276(38):35622-28.
6. Basu, S., Bayoumy, S., Zhang, Y. et al. 1998. BAD enables ceramide to signal apoptosis via Ras and Raf-1. J. Biol. Chem., 273(46):30419-26.
7. Batheja, A.D., Uhlinger, D.J., Carton, J.M. et al. 2003. Characterization of serine palmitoyltransferase in normal human tissues. J. Histochem. Cytochem., 51(5):687-96.
8. Bektas, M., Jolly, P.S., Muller, C. et al. 2005. Sphingosine kinase activity counteracts coramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene., 24(1):178-87.
9. Berger, A., Bittman, R., Schmidt, R.R. et al. 1996. Structural requirements of sphingosylphosphocholine and sphingosine-1-phosphate for stimulation of activator protein-1 activity. Mol. Pharmacol., 50(3):451-7.
10. Bornancin, F., Mechtcheriakova, D., Stora, S. et al. 2005. Characterization of a ceramide kinase-like protein. Biochim Biophys. Acta., 1687(1-3):31-43.
11. Boudker, O. and Futerman, A.H. 1993. Detection and characterization of ceramide-1-phosphate phosphatase activity in rat liver plasma membrane. J. Biol. Chem., 268(29):22150-55.
12. Brindley, D.N. and Waggoner, D.W. 1996. Phosphatidate phosphohydrolase and signal transduction. Chem. Phys. Lipids, 80(1-2):45-57.
13. Brindley, D.N. and Waggoner, D.W. 1998. Mammalian lipid phosphate phosphohydrolases. J. Biol. Chem., 273(38):24281-84.
14. Cardone, M.H., Roy, N., Stennicke, H.R. et al. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science, 282 (5392):1318-21.
15. Carpio, L.C., Stephan, E., Kamer, A. et al. 1999 Nov. Sphingolipids stimulate cell growth via MAP kinase activation in osteoblastic cells. Prostaglandins Leukot Essent, Fatty Acids, 61(5):267-73.
16. Cazzolli, R., Carpenter, L., Biden, T.J. et al. 2001. A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate. Diabetes, 50:2210-18.
17. Exton, J.H. 1998. Phospholipase D. Biochim Biophys. Acta., 1436 (1-2):105-15.
18. Chalfant, C.E., Ogretmen, B., Galadari, S., Kroesen, B.J., Pettus, B.J. and Hannun, Y.A. 2001. FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase. J. Biol. Chem., 276(48):44848-55.
19. Chalfant, C.E. 2004. Ceramide kinase, in Lipids: Sphingolipid Metabotizing Enzymes Research Signpost, Kerala, India.
20. Chalfant, C.E. and Spiegel, S. 2005. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell. Sci., 118(Pt 20):4605-12.
21. Chen, J.S. and Exton, J.H. 2004. Regulation of phospholipase D2 activity by protein kinase C alpha. J. Biol. Chem., 279(21):22076-83.
22. Chen, J.S. and Exton, J.H. 2005. Sites on phospholipase D2 phosphorylated by PKCalpha. Biochem. Biophys. Res. Commun., 333(4):1322-26.
23. Clair, T., Aoki, J., Koh, E. et al. 2003. Autotaxin hydrolyzes sphingosyl-phosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res., 63(17):5446-53.
24. Colina, C., Flores, A., Castillo, C. et al. 2005. Ceramide-1-phosphate induces Ca2+ mobilization in Jurkat T-cells by elevation of Ins(1,4,5)-P3 and activation ofa storeoperated calcium channel. Biochim. Biophys. Res. Commun., 336:54-60.
25. Coroneos, E., Wang, Y., Panuska, J.R. et al. 1996. Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem. J., 316(1):13-17.
26. Cuvillier, O., Pirianov, G., Kleuser, B. et al. 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 381(6585):800-3.
27. Davis, M.D., Clemens, J.J., Macdonald, T.L. et al. 2005. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem., 280(11):9833-41.
28. Desai, N.N., Zhang, H., Olivera, A. et al. 1992. Sphingosina-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation. J. Biol. Chem., 267(32):23122-28.
29. De Chaves, E.I., Bussiere, M., Vance, D.E. et al.. 1997. Elevation of ceramide within distal neurites inhibits neurite growth in cultured rat sympathetic neurons. J. Biol. Chem., 272(5):3028-35.
30. De Stefanis, D., Reffo, P., Bonelli, G. et al. 2002. Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells. Biol. Chem., 383(6):989-99.
31. Donati, C. and Bruni, P. 2006. Sphingosine 1-phosphate regulates cytoscheleton dynamics: Implications in its biological response. Biochim Biophys. Acta., 1758 (12):2037-48.
32. Dobrowsky, R.T. and Hannun, Y.A. 1992. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem., 267(8):5048-51.
33. Dorsam, R.T. and Gutkind, J.S. 2007. G-proteiris coupled receptors and cancer. Nat. Rev. Cancer, 7(2):79-94.
34. Dragusin, M., Wehner, S., Kelly, S. et al. 2006. Effects of sphingosine-1-phosphate and ceramide-1-phosphate on rat intestinal smooth muscle cells: implications for postoperative ileus. FASEB. J. 20(11):1930-32.
35. Dressler, K.A. and Kolesnick, R.N. 1990. Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells. Synthesis via ceramide from sphingomyelin. J. Biol. Chem., 265(25):14917-21.
36. Duan, R.D. 2006. Alkaline sphingomyelinase: an old enzyme with novel implications. Biochim. Biophys. Acta., 1761(3):281-91.
37. Epand, R.M. 1985. Diacylglycerols, lysolecithin, or hydrocarbons markedly alter the bilayer to hexagonal phase transition temperature of phosphatidylethanolamines. Biochemistry, 24:7092-95.
38. French, K.J., Upson, U., Keller, S.N. et al. 2006. Antitumor Activity of Sphingosine Kinase Inhibitors. J. Pharmacol. Exp. Ther., 318(2):596-603.
39. French, K.J., Schrecengost, R.S., Lee, B.D. et al. 2003. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res., 63(18):5962-69.
40. Gijsbers, S., Mannaerts, G.P., Himpens, B. et al. 1999. N-acetylsphingenine-1-phosphate is a potent calcium mobilizing agent. FEBS Lett, 453:269-72.
41. Giussani, P., Maceyka, M., Le Stunff, H. et al. 2006. Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide. Mol. Cell. Biol., 26(13):5055-69.
42. Gómez-Muñoz, A., Haniza, E.H. and Brindley, D.N. 1992. Effects of sphingosine, albumin and unsaturated fatty acids on the activation and translocation of phosphatidate phosphohydrolases in rat hepatocytes. Biochim. Biophys. Acta., 1127(1):49-56.
43. Gómez-Muñoz, A., Martin, A., O'Brien, L. et al. 1994. Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. J. Biol. Chem., 269(12):8937-43.
44. Gómez-Muñoz, A., Duffy, P.A., Martin, A. et al. 1995. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. Mol. Pharmacol., 47(5):883-9.
45. Gómez-Muñoz, A., Waggoner, D.W., O'Brien, et al. 1995. Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. J. Biol. Chem., 270(44):26318-25.
46. Gómez-Muñoz, A., Frago, L.M., Alvarez, L. et al. 1997. Stimulation of DNA synthesis by natural ceramide 1-phosphate. Biochem. J., 235:435-40.
47. Gómez-Muñoz, A. 1998. Modulation of cell signalling by ceramides. Biochim Biophys. Acta., 1391(1):92-109.
48. Gómez-Muñoz, A., Martens, J.S. and Steinbrecher, U.P. 2000. Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages. Arterioscler Thromb Vasc. Biol., 20(1):135-43.
49. Gómez-Muñoz, A., Kong, J., Salh, B. et al. 2003. Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett, 539(1-3):56-60.
50. Gómez-Muñoz, A. 2004. Ceramide-1-phosphate: a novel regulator of cell activation. FEBS Lett, 562(1-3):5-10.
51. Gómez-Muñoz, A., Kong, J.Y., Salh, B. et al. 2004. Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J. Lipid Res., 45(1):99-105.
52. Gómez-Muñoz, A., Kong, J.Y., Parhar, K. et al. 2005. Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase/protein kinase B pathway. FEBS Lett, 579(17):3744-50.
53. Gómez Muñoz, A. 2006. Ceramide 1-phosphate/ceramide, a switch between life and death. Biochim. Biophys. Acta., 1758(12):2049-56.
54. Gómez-Muñoz, A. 2006. Sphingomyelinases and the regulation of cell death and survival. Curr Enzyme Inhibition, 2:125-34.
55. Gohi, F.M. and Alonso, A. 2006. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim. Biophys. Acta., 1758(12):1902-21.
56. Gofti, F.M. and Alonso, A. 2002. Sphingomyelinases: enzymology and membrane activity. FEBS Lett, 531(1):38-46.
57. Gouaze-Andersson, V. and Cabot, M.C. 2006. Glycosphingolipids and drug resistance. Biochim Biophys. Acta., 1758(12):2096-103.
58. Gouaze, V., Liu, Y.Y., Prickett, C.S. et al. 2005. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res., 65(9):3861-7.
59. Gulbins, E. and Kolesnick, R. 2003. Raft ceramide in molecular medicine. Oncogene, 22(45):7070-77.
60. Hait, N.C., Oskeiritzian, C.A., Paugh, S.W. et al. 2006. Sphingosine kinase, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta., 1758(12):2116-2026.
61. Hajduch, E., Litherland, G.J. and Hundal, H.S. 2001. Protein kinase B (PKB/Akt)-a key regulator of glucose transport? FEBS Lett, 492(3):199-203.
62. Hanada, K. 2006. Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol. Cell. Biochem., 286(1-2):23-31.
63. Hanada, K., Kumagai, K., Yasuda, S. et al. 2003. Molecular machinery for non-vesicular trafficking of ceramide. Nature, 426(6968):803-9.
64. Hannun, YA., Loomis, C.R. and Bell, R-M. 1986. Protein kinase C activation in mixed micelles. Mechanistic implications of phospholipid, diacylglycerol, and calcium interdependencies. J. Biol. Chem., 261(16):7184-90.
65. Hannun, Y.A., Loomis, C.R., Merrill, A.H. Jr et al. 1986. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem., 261(27):12604-9.
66. Hannun, Y.A. 1994. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem., 269(5):3125-8.
67. Hannun, Y.A. and Obeid, L.M. 1995. Ceramide: intracellular signal for apoptosis. Trends Biochem. Sci., 20:73-9.
68. Hannun, Y.A. 1996. Functions of ceramide in coordinating cellular responses to stress. Science, 274(5294):1855-9.
69. Hannun, Y.A. and Obeid, L.M. 2002. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem., 277(29):25847-50.
70. Heasley, L.E., Thaler, S., Nicks, M. et al. 1997. Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J B.iol. Chem., 272(23):14501-4.
71. Hertervig, E., Nilsson, A., Cheng, Y. et al. 2003. Purified intestinal alkaline sphingoinyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells. J. Cancer Res. Clin. Oncol., 129(10):577-82.
72. Hinkovska-Galcheva, V.T., Boxer, L.A., Mansfield, P.J. et al. 1998. The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J. Biol. Chem., 273(50):33203-9.
73. Hinkovska-Galcheva, V.T., Boxer, L.A., Kindzelskii, A. et al. 2005. Ceramide 1-phosphate, a mediator of phagocytosis. J. Biol. Chem., 280 (28):26612-21.
74. Hla, T. 2003. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol. Res., 47(5):401-7.
75. Hong, K.H., Bonventre, J.C., O'Leary, E. et al. 2001. Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis. Proc. Natl. Acad Sci. U.S.A., 98(7):3935-9.
76. Hogback, S., Leppimaki, P., Rudnas, B. et al. 2003. Ceramide 1-phosphate increases intracellular free calcium concentrations in thyroid FRTL-5 cells: evidence for an effect mediated by inositol 1,4,5-trisphosphate and intracellular sphingosine 1-phosphate. Biochem. J., 370(Pt 1): 111-9.
77. Hu, T. and Exton, J.H. 2003. Mechanisms of regulation of phospholipase D1 by protein kinase Calpha. J. Biol. Chem., 278(4):2348-55.
78. Hundal, R.S., Gomez-Munoz, A., Kong, J.Y. et al. 2003. Oxidized low density lipoprotein inhibits macrophage apoptosis by blocking ceramide generation, thereby maintaining protein kinase B activation and Bcl-XL levels. J .Biol. Chem., 278(27):24399-408.
79. Hundal, R.S., Salh, B.S., Schrader, J.W. et al. 2001. Oxidized low density lipoprotein inhibits macrophage apaptosis through activation of the PI 3 -kinase/PKB pathway. J. Lipid Res., 42(9):1483-91.
80. Ichimura, K., Schmidt, E., Miyakopwa, A. et al. 1998. Common Regions of Deletion on Chromosomes 5q, 6q, and 10q in Renal Cell Carcinoma. Genes Chromosomes Cancer, 22:9-15.
81. Inokuchi, J., Jimbo, M., Mimosaki, K. et al. 1990: Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action. Cancer Res., 50(20):6731-9.
82. Itagaki, K. and Hauser, C.J. 2003. Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry. J Biol. Chem., 278(30):27540-47.
83. Jamal, Z., Martin, A., Gómez-Munoz, A. et al. 1991. Plasma membrane fractions from rat liver contain a phosphatidate phosphohydrolase distinct from that in the endoplasmic reticulum and cytosol. J. Biol. Chem., 266(5):2988-96.
84. Jaworowski, A., Wilson, N.J., Christy, E. et al. 1999. Roles of the mitogen-activated protein kinase family in macrophage responses to colony stimulating factor-1 addition and withdrawal. J. Biol. Chem., 274(21):15127-33.
85. Johnson, K.R., Becker, K.P., Facchinetti, M.M. et al. 2002. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem., 277(38):35257-62.
86. Johnson, K.R., Johnson, K.Y., Becker, K.P. et al. 2003. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. J Biol. Chem., 278(36):34541-7.
87. Johnson, K.R., Johnson, K.Y., Crellin, H.G. et al. 2005. Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J. Histochem. Cytochem., 53(9):1159-66.
88. Kim, J.W., Inagaki, Y., Mitsutake, S. et al. 2005. Suppression of mast cell degranulation by a novel ceramide kinase inhibitor, the F-12509A olefin isomer K1. Biochim. Biophys. Acta., 1738(1-3):82-90.
89. Kinnunen, PKJ. 1996. On the molecular level mechanisms of peripheral protein/membrane interactions induced by lipids forming non-lamellar phases. Chem. Phys. Lipids, 81:151-66.
90. Kitatani, K., Idkowiak-Baldys, J. and Hannun, Y.A. 2007. Mechanism of inhibition of sequestration of protein kinase C alpha/betaII by ceramide. Roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alphalbetaII. J. Biol. Chem., 282(28):20647-56.
91. Kleuser, B., Maceyka, M., Milstien, S. et al. 2001. Stimulation of nuclear sphingosine kinase activity by platelet-derived growth factor. FEBS Lett, 503(1):85-90.
92. Kolesnick, R.N. 1987. 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J. Biol. Chem., 262(35):16759-62.
93. Kolesnick, R.N. and Hemer, M.R. 1990. Characterization ofa ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity. J. Biol. Chem., 265(31):18803-08.
94. Kolesnick, R.N. 1994. Signal transduction through the sphingomyelin pathway. Mot. Chem. Neuropathol., 21(2-3):287-97.
95. Kolesnick, R.N. and Golde, D.W. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell., 77(3):325-8.
96. Kolesnick, R.N., Goni, F.M. and Alonso, A. 2000. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell. Physiol., 184(3):285-300.
97. Kolesnick, R.N. 2002. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest., 110(1)-3-8.
98. Kohno, M., Momoi, M., Oo, M.L. et al. 2006. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol., 26(19):7211-23.
99. Kon, J., Sato, K., Watanabe, T. et al. 1999. Comparison of intrinsic activities of the putative sphingosine1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J. Biol. Chem., 274:23940-7.
100. Koybasi, S., Senkal, C.E., Sundararaj, K. et al. 2004. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem., 279(43):44311-9.
101. Lamour, N.F. and Chalfant, C.E. 2005. Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation. Mol. Interv., 5(6):358-67.
102. Le Stunff, H., Milstien, S. and Spiegel, S. 2004. Generation and metabolism of bioactive sphingosine-1-phosphate. J. Cell. Biochem., 92(5):882-99.
103. Le Stunff, H., Galve-Roperh, I., Peterson, C. et al. 2002. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J. Cell. Biol., 158(6):1039-49.
104. Lee, S. and Lynch, K.R. 2005. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA). Biochem. J., 391:317-23.
105. Lee, J.Y., Hannun, Y.A. and Obeid, L.M. 1996. Ceramide inactivates cellular protein kinase Calpha. J. Biol. Chem., 271(22):13169-74.
106. Liu, J., Mathias, S., Yang, Z. et al. 1994. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem., 269(4):3047-52.
107. Liu, Y.Y., Han, T.Y., Giuliano, A.E. et al. 2000. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin, resistance. J. Biol. Chem., 275:7138-43.
108. Liu, H., Toman, R.E., Goparaju, S.K. et al. 2003. Sphingosine kinase type 2 is aputative BH3-only protein that induces apoptosis. J. Biol. Chem., 278(41):40330-6.
109. Long, J., Darroch, P., Wan, K.F. et al. 2005. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. Biochem. J., 391(Pt 1):25-32.
110. Lozano, J., Berra, E., Municio, M.M. et al. 1994. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingemyelinase. J. Biol. Chem., 269(30):19200-2.
111. Luberto, C. and Hannun, Y.A. 1998. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J. Biol. Chem., 273(23):14550-59.
112. Lu, F.G., Wong, C.S. et al. 2004. Radiation-induced apoptosis of oligodendrocytes and its association with increased ceramide and down-regulated protein kinase B/Akt activity. Int. J. Radiat. Biol., 80(1):39-51.
113. Maceyka, M., Payne, S.G., Milstien, S. et al. 2002. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys. Acta., 1585(2-3):193-201.
114. Maceyka, M., Sankala, H., Hait, N.C. et al. 2005. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem., 280(44):37118-19.
115. Mackintosh, C. 2004. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem. J., 381(Pt 2):329-42.
116. Magrassi, L., Adorni, L., Montorfano, G. et al. 1998. Vitamin D metabolites activate the sphingomyelin pathway and induce death of glioblastoma cells. Acta. Neurochir., 140(7):707-14.
117. Malisan, F. and Testi, R. 1999. Lipid signaling in CD95-mediated apoptosis. FEBS Lett, 452(1-2):100-3.
118. Martin, A., Duffy, P.A., Liossis, C. et al. 1997. Increased concentrations of phosphatidate, diacylglycerol and ceramide in ras- and tyrosine kinase (fps)-transformed fibroblasts. Oncogene, 14(13):1571-80.
119. Mathias, S. and Kolesnick, R.N. 1993. Ceramide: a novel second messenger. Adv. Lipid Res., 25:65-90.
120. Mattie, M., Brooker, G. and Spiegel, S. 1994. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an mositol trisphosphate-independent pathway. J. Biol. Chem., 269(5):3181-8.
121. Mauret, B.J., Melton, L., Billups, C. et al. 2000. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxypheny)retinamide and modulators of ceramide metabolism. J. Natl. Cancer Inst., 92:1897-909.
122. Mechtcheriakova, D., Wlachos, A., Sobanov, J. et al. 2007. Sphingosine 1-phosphate phosphatase 2 is induced during inflammatory responses. Cell. Signal, 19(4):748-60.
123. Merrill, A.H. Jr and Jones, P.D. 1990. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim. Biophys. Acta., 1044(1):1-12.
124. Meyer zu Heringdorf, D., Liliom, K., Schaefer, M. et al. 2003. Photolysis of intracellular caged sphingosine-1-phosphate causes Ca2+ mobilization independently of G-protein-coupled receptors, FEBS Lett, 554(3):443-9.
125. Milstien, S. and Spiegel, S. 2006 Mar. Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell., 9(3):148-50.
126. Mitra, P., Maceyka, M., Payne, S.G. et al. 2007. Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells. FEBS Lett, 581(4):735-40.
127. Miura, Y., Gotoh, E., Nara, F. et al. 2004. Hydrolysis of sphingosylphosphocholine by neutral sphingomyelinases. FEBS Lett, 557 (1-3):288-92.
128. Modrak, D.E., Gold, D.V. and Goldenberg, D.M. 2006. Sphingolipid targets in cancer therapy. Mol. Cancer R. Ther., 5:200-8.
129. Morales, M.C., Perez-Yarza, G., Rementeria, N.N. et al. 2007. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bel-2. Free Radic. Res., 41(5):591-601.
130. Moussavi, M., Assi, K., Gómez-Muñoz, et al. 2006. Curcumin mediates ceramide generation vis the de novo pathway in colon cancer cells. Carcinogenesis, 27(8):1636-44.
131. Muller, G., Ayoub, M., Storz, P. et al. 1995. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J., 14(9):1961-9.
132. Nava, V.E., Hobson, J.P., Murthy, S. et al. 2002. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp. Cell. Res., 281:115-27.
133. Natarajan, V, Jayaram, H.N., Scribner, W.M. et al. 1994. Activation of endothelial cell phospholipase D by sphingosine and sphingosine-1-phosphate. Am. J. Respir. Cell. Mol. Biol., 11(2):221-9.
134. Ogawa, C., Kihara, A., Gokoh, M. et al. 2003. Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J. Biol. Chem., 278(2):1268-72.
135. Ogretmen, B., Pettus, B.J., Rossi, M.J. et al. 2002. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide. J. Biol. Chem., 277(15):12960-9.
136. Okamoto, H., Takuwa, N., Gonda, K. et al. 1998. EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J. Biol. Chem., 273(42):27104-10.
137. Okazaki, T., Bell, R.M. and Hannun, Y.A. 1989. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J. Biol. Chem., 264:19076-80.
138. Okazaki, T., Bielawska, A., Bell, R.M. et al. 1990. Role of ceramide as a lipio mediator of 1 alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem., 265(26):15823-31.
139. Olivera, A. and Spiegel, S. 1993. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature, 365:557-60.
140. Osawa, Y., Banno, Y., Nagaki, M. et al. 2001. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J. Immunol., 167(1):173-80.
141. Oskouian, B., Sooriyakumaran, P., Borowsky, A.D. et al. 2006. Sphingosine 1-phosphate lyase potentiates apoptosis via p53 and p38 dependent pathways and is down-regulated in colon cancer. PNAS, 13(46):17384-9.
142. Osterstrom, A., Dimberg, J., Fransen, K. et al. 2002. Expression of cytosolic and group X secretory phospholipase A(2) genes in human colorectal adenocarcinomas. Cancer Lett, 182(2):175-82.
143. Pappu, R., Schwab, S.R., Cornelissen, I. et al. 2007. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science, 316(5822):295-8.
144. Payne, S.G., Milstien, S. and Spiegel, S. 2002. Sphingosine-1-phosphate: dual messenger function s. FEBS Lett, 531(1):54-7.
145. Perez-Andres, E., Fernandez-Rodriguez, M., Gonzalez, M. et al. 2002. Activation of phospholipase D-2 by P2X(7) agonists in rat submandibular gland acini. J. Lipid Res., 43(8):1244-55.
146. Petersen, I., Hidalgo, A., Petersen, S. et al. 2000. Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol., 10(3):395-401.
147. Petersen, S., Wolf, G., Bockmühl, U. et al. 1998. Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br. J. Cancer, 77(2):270-6.
148. Pettus, B.J., Kitatani, K., Chalfant, C.E. et al. 2005. The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol. Pharmacol., 68(2):330-5.
149. Pettus, B.J., Bielawska, A., Subramanian, P. et al. 2004. Ceramide 1-phos-phate is a direct activator of cytosolic phospholipase A2. J. Biol. Chem., 279(12):11320-6.
150. Pettus, B.J., Bielawska, A., Spiegel, S. et al. 2003. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. J. Biol. Chem., 278(40):38206-13.
151. Pettus, B.J., Chalfant, C.E. and Hannun, Y.A. 2002. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys. Acta., 1585(2-3):114-25.
152. Plummer, G., Perreault, K.R., Holmes, C.F. et al. 2005. Activation of serine/threonine protein phosphatase-1 is required for ceramide-induced survival of sympathetic neurons. Biochem. J., 385(3):685-93.
153. Pyne, S. and Pyne, N.J. 2000. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J., 349:395-402.
154. Raisova, M., Goltz, G., Bektas, M. et al. 2002. Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Lett, 516(1-3):47-52.
155. Rani, C.S., Wang, F., Fuior, E. et al. 1997. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling. J. Biol. Chem., 272(16):10777-83.
156. Reiss, U., Oskouian, B., Zhou, J. et al. 2004. Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J. Biol. Chem., 279(2):1281-90.
157. Reyes, J.G., Robayna, J.G., Delgado, P.S. et al. 1996. c-Jun is a downstream target for ceramide-activated protein phosphatase in A431 cells. J. Biol. Chem., 271(35):21375-80.
158. Reynolds, C.P., Maurer, B.J. and Kolesnick, R.N. 2004. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett, 206(2):169-80.
159. Ribatti, D., Raffaghello, L., Marimpietri, D. et al. 2003. Fenretinide as an antiangiogenic agent in neuroblastoma. Cancer Lett, 197(1-2):181-4.
160. Riboni, L., Bassi, R., Anelli, V. et al. 2002. Metabolic formation of ceramide-1-phosphate in cerebellar granule cells: evidence for the phosphorylation of ceramide by different metabolic pathways. Neurochem. Res., 27(7-8):711-6.
161. Riboni, L., Campanella, R., Bassi, R. et al. 2002. Ceramide levels are inversely associated with malignant progression of human glial tumors. Glia, 39(2):105-13.
162. Rile, G., Yatomi, Y., Takafuta, T. et al. 2003. Ceramide 1-phosphate formation in neutrophils. Acta. Haematol., 109:76-83.
163. Rosenfeldt, H.M., Hobson, J.P., Maceyka, M. et al. 2001. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. FASEB. J., 15(14):2649-59.
164. Ruvolo, P.P., Deng, X., Ito, T. et al. 1999. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem., 274(29):20296-300.
165. Ruvolo, P.P., Deng, X., Carr, B.K. et al. 1998. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem., 273(39):25436-42.
166. Rylova, S.N., Somova, O.G. and Dyatlovitskaya, E.V. 1998. Comparative investigation of sphingoid bases and fatty acids in ceramides and sphingomyelins from human ovarian malignant tumors and normal ovary. Biochemistry (Mosc), 63(9):1057-60.
167. Saba, J.D. and Hla, T. 2004. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ. Res., 94(6):724-34.
168. Sabbadini, R.A. 2006. Targeting sphingosine-1-phosphate for cancer therapy. Br. J. Cancer, 95(9):1131-35.
169. Sakane, F., Yamada, K. and Kanoh, H. 1989. Different effects of sphingosine, R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. FEBS Lett, 255(2):409-13.
170. Salinas, M., Lopez-Valdaliso, R., Martin, D. et al. 2000. Inhibition of PKB/ Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol. Cell. Neurosci, 15(2):156-69.
171. Samet, D. and Barenholz, Y. 1999. Characterization of acidic and neutral sphingomyelinase activities in crude extracts of HL-60 cells. Chem. Phys. Lipids, 102(1-2):65-77.
172. Santana, P., Pena, L.A., Haimovitz-Friedman, A. et al. 1996. Acid sphingo-myelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell., 86(2):189-99.
173. Sarkar, S., Maceyka, M., Hait, N.C. et al. 2005. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett, 579(24):5313-17.
174. Sato, S., Fujita, N. and Tsuruo, T. 2000. Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. U.S.A, 97(20):10832-37.
175. Sawai, H., Okazaki, T., Yamamoto, H. et al. 1995. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem., 270:27326-31.
176. Scheid, M.P., Marignani, P.A. and Woodgett, J.R. 2002. Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol. Cell. Biol., 22(17):6247-60.
177. Scheid, M.P. and Woodgett, J.R. 2003. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett, 546(1):108-12.
178. Schmitz-Peiffer, C., Craig, D.L. and Biden, T.J. 1999. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J. Biol. Chem., 274(34):24202-10.
179. Schuchman, E.H., Suchi, M., Takahashi, T. et al. 1991. Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J. Biol. Chem., 266(13):8531-9.
180. Seelan, R.S., Qian, C., Yokomizo, A. et al. 2000. Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer, 29(2):137-46.
181. Ségui, B., Andrieu-Abbadie, N., Jaffrézou, J-P. et al. 2006. Sphingolipids as modulators of cancer cell death: Potential therapeutic targets. Biochim Biophys. Acta., 1758 (12):2104-20.
182. Selzner, M., Bielawska, A., Morse, M.A. et al. 2001. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res., 61(3):1233-40.
183. Senchenkov, A., Litvak, D.A. and Cabot, M.C. 2001. Targeting ceramide metabolism-a strategy for overcoming drug resistance. J. Natl. Cancer Inst., 93:347-57.
184. Shinghal, R., Scheller, R.H. and Bajjalieh, S.M. 1993. Ceramide-1-phosphate phosphatase activity in brain. J. Neurochem., 61:2279-85.
185. Spiegel, S., Olivera, A. and Carlson, R.O. 1993. The role of sphingosine in cell growth regulation and transmembrane signaling. Adv Lipid Res., 25:105-29.
186. Spiegel, S., Foster, D. and Kolesnick, R. 1996. Signal transduction through lipid second messengers. Curr. Opin. Cell. Biol., 8:159-67.
187. Spiegel, S. and Merrill, A.H. Jr. 1996. Sphingolipid metabolism and cell growth regulation. FASEB. J., 10(12):1388-97.
188. Spiegel, S. and Milstien, S. 2000. Sphingosine-1-phosphate: signaling inside and out. FEBS Lett, 476:55-67.
189. Spiegel, S. and Milstien, S. 2000. Functions of a new family of sphingosine-1-phosphate receptors. Biochim Biophys. Acta., 1484(2-3):107-16.
190. Spiegel, S. and Milstien, S. 2002. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem., 77(29):25851-54.
191. Spiegel, S. and Milstien, S. 2003. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell. Biol., 4(5):397-407.
192. Subramaman, P., Stahelin, R.V., Szulc, Z., et al. 2005. Ceramide 1-phosphate acts as a positive allosteric activator of group IVA cytosolic phospholipase A2 alpha and enhances the interaction of the enzyme with phosphatidylcholine. J. Biol. Chem., 280(18):17601-7.
193. Subbaramaiah, K. and Dannenberg, A.J. 2003. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci., 24(2):96-102.
194. Schẗze, S., Potthoff, K., Machleidt, T. et al. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyclin breakdown. Cell., 71:765-76.
195. Sugiura, M., Kono, K., Liu, H. et al. 2002. Ceramide kinase, a novel lipid kinase. Molecular cloning and characterization. J. Biol. Chem., 277:23294-300.
196. Taha, T.A., Argraves, K.M. and Obeid, L.M. 2004. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim. Biophys. Acta., 1682(1-3):48-55.
197. Taha, T.A., Osta, W., Kozhaya, L. et al. 2004. Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53. J. Biol. Chem., 279(l9):20546-52054.
198. Taha, T.A., Mullen, T.D. and Obeid, L.M. 2006. A house divided: Ceramide, sphingosine, and Sphingosine-1-phosphate in programmed cell death. Biochim. Biophys. Acta., 1758(12):2027-36.
199. Taketo, M.M. 1998. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J. Natl. Cancer Inst., 90:1529-36.
200. Tani, M., Sano, T., Ito, M. et al. 2005. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. J. Lipid Res., 46(11):2458-67.
201. Testai, F.D., Landek, M.A., Goswami, R. et al. 2004. Acid sphingomyelinase and inhibition by phosphate ion: role of inhibition by phosphatidyl-myo-inositol 3, 4, 5-triphosphate in oligodendrocyte cell signaling. J. Neurochem., 89(3):636-44.
202. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science, 267(5203):1456-62.
203. Tornquist, K., Blom, T., Shariatmadari, R. et al. 2004. Ceramide 1-phosphate enhances calcium entry through voltage-operated calcium channels by a protein kinase C-dependent mechanism in GH4C1 rat pituitary cells. Biochem. J., 380(3):661-8.
204. Truett, A.P. 3rd and King, L.E. Jr. 1993. Sphingomyelinase D: a pathogenic agent produced by bacteria and arthropods. Adv. Lipid Res., 26:275-91.
205. Tuson, M., Marfany, G. and Gonzalez-Duarte, R. 2004. Mutation of CERKL, a novel human ceramide-kinase gene, causes autosomal recessive retinitis pigmentosa (RP26). Am. J. Hum. Genet., 74(1):128-38.
206. Vann, L.R., Payne, S.G., Edsall, L.C. et al. 2002. Involvement of sphingosine kinase in TNF-alpha-stimulated tetrahydrobiopterin biosynthesis in C6 glioma cells. J. Biol. Chem., 277(15):12649-56.
207. Vaux, D.L. and Korsmeyer, S.J. 1999. Cell death in development. Cell., 96(2):245-54.
208. Villullas, I.R., Smith, A.J., Heavens, R.P. et al. 2003. Characterisation of a sphingosine 1 -phosphate-activated Ca2+ signalling pathway in human neuroblastoma cells. J. Neurosci. Res., 73(2):215-26.
209. Visentin, B., Vekich, J.A., Sibbald, B.J. et al. 2006. Validation of an anti-sphingosine-1-pbosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell., 9(3):225-38.
210. Vunnam, R.R. and Radin, N.S. 1980. Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain. Chem. Phys. Lipids, 26:265-78.
211. Waggoner, D.W., Gomez-Munoz, A., Dewald, J. et al. 1996. Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate. J. Biol. Chem., 271(28):16506-9.
212. Wang, F., Van Brocklyn, J.R., Hobson, J.P. et al. 1999. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem., 274:35343-50.
213. Wang, S.W., Parhar,,K., Chiu, K.J. et al. 2007, Pertussis toxin promotes macrophage survival through inhibition of acid sphingomyelinase and activation of the phosphoinositide 3-kinase/protein kinase B pathway. Cell. Signal, 19(8):1772-83.
214. Watterson, K., Sankala, H., Milstien, S. et al. 2003. Pleiotropic actions of sphingosinc-1-phosphate. Prog. Lipid Res., 42(4):344-57.
215. Watts, A. 1993. Protein-Lipid Interactions. New York: Elsevier Science.
216. Wijesinghe, D.S., Massiello, A., Subramanian, P. et al. 2005. Substrate specificity of human ceramide kinase. J. Lipid Res., 46(12):2706-16.
217. Wolff, R.A., Dobrowsky, R.T., Bielawska, A. et al. 1994. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J. Biol. Chem., 269(30):19605-9.
218. Wu, J., Cheng, Y., Nilsson, A. et al. 2004. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis, 25(8):1327-33.
219. Wu, J., Spiegel, S. and Sturgill, T. W. 1995. Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G proteindependent mechanism. J. Biol. Chem., 270:11484-8.
220. Xia, P., Gamble, J.R., Wang, L. et al. 2000. An oncogenic role of sphingosine kinase. Curr. Biol., 10: 1527-30.
221. Xia, P., Wang, L., Moretti, P.A. et al. 2002. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling. J. Biol. Chem., 277(10):7996-8003.
222. Xu, Y. 2002. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim. Biophys. Acta., 1582(1-3):81-8.
223. Yamada, K., Sakane, F., Imai, S. et al. 1993. Sphingosine activates cellular diacylglycerol kinase in intact Jurkat cells, a human T-cell line. Biochim. Biophys. Acta., 1169(3):217-24.
224. Yamada, M., Banno, Y., Takuwa, Y. et al. 2004. Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells. Biochem. J., 378(2):649-56.
225. Yao, B., Zhang, Y., Delikat, S. et al. 1995. Phosphorylation of Raf by ceramide-activated protein kinase. Nature, 378(6554):307-10.
226. Zeidan, Y.H. and Hannun, Y.A. 2007. Activation of acid sphingomyetinase by protein kinase Cγ mediated phosphorylation. J. Lipid Res., 282(15):11549-6l.
227. Zhao, Y, Usatyuk, P.V., Cummings, R. et al. 2005. Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. Biochem. J., 385(Pt 2):493-502.
228. Zhang, H., Buckley, N.E., Gibson, K. et al. 1990. Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway. J. Biol. Chem., 265(1):76-81.
229. Zhang, Y. and Kolesnick, R. 1995. Signaling through the sphingomyelin pathway. Endocrinology, 136(10):4157-60.
230. Zhang, Y, Yao, B., Delikat, S. et al. 1997. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell., 89(1):63-72.
231. Zhang, J. and Xu, M. 2002. Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell. Biol., 12(2):84-9.
232. Zhou, H., Summers, S.A., Birnbaum, M.J. et al. 1998. N. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J. Biol. Chem., 273(26):16568-75.